Glycotope GmbH
Trending Articles
Related Content
Research & Development
DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms
DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno-oncology company built on world-leading glycobiology expertise, have expanded their existing partnership through a new research collaboration and licensing agreement
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Pharmaceutical
Glyco-optimisation of biotherapeutics
Glycosylation can have a big effect on the yields and on the biologic and clinical properties of proteins and vaccines, affecting not only the bioavailability of biopharmaceuticals but also the activity, immunogenicity, antigenicity, solubility and stability of proteins.